Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.06 USD | +0.49% | -6.79% | -70.66% |
Financials (USD)
Sales 2024 * | 428K | Sales 2025 * | 300K | Capitalization | 6.38M |
---|---|---|---|---|---|
Net income 2024 * | -26M | Net income 2025 * | -33M | EV / Sales 2024 * | 14.9 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 21.3 x |
P/E ratio 2024 * |
-0.44
x | P/E ratio 2025 * |
-0.53
x | Employees | 19 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.2% |
Latest transcript on TFF Pharmaceuticals, Inc.
1 day | +0.49% | ||
1 week | -6.79% | ||
1 month | -16.60% | ||
3 months | -69.47% | ||
6 months | -77.11% | ||
Current year | -70.66% |
Managers | Title | Age | Since |
---|---|---|---|
Harlan Weisman
CEO | Chief Executive Officer | 71 | 18-11-30 |
Kirk Coleman
DFI | Director of Finance/CFO | 51 | 18-01-23 |
Zamaneh Mikhak
CTO | Chief Tech/Sci/R&D Officer | 58 | 23-01-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 52 | 18-11-30 | |
Brandi Roberts
BRD | Director/Board Member | 50 | 22-03-24 |
Thomas King
BRD | Director/Board Member | 69 | Dec. 12 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 2.06 | +0.49% | 7,100 |
24-05-30 | 2.05 | -.--% | 23,102 |
24-05-29 | 2.05 | -7.24% | 23,982 |
24-05-28 | 2.21 | -.--% | 31,272 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-70.66% | 6.38M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- TFFP Stock